Answers are grounded in this paper and cite their sources.
Observational study finds high rates of MDR infections in neutropenic patients, indicating urgent need for improved therapeutic strategies.
BACKGROUND: Bloodstream infections (BSIs) cause significant morbidity and mortality in neutropenic patients with hematological malignancies, especially amid rising antimicrobial resistance. Updated local data are essential to guide empirical therapy. OBJECTIVES: The aims of this study were to assessed the etiology, resistance patterns, clinical outcomes of BSIs, and the diagnostic performance of real-time PCR (RT-PCR) versus conventional blood culture. MATERIALS AND METHODS: A prospective observational study was conducted at Azadi Teaching Hospital (September 2024–May 2025) on 109 neutropenic adults. Blood cultures and multiplex RT-PCR were used to identify pathogens and resistance genes. Clinical features, antimicrobial susceptibility, and 30-day outcomes were analyzed. RESULTS: BSIs occurred in 24 patients (22%). Blood culture positivity was low (3.7%), while RT-PCR detected pathogens in 20.2%, increasing diagnostic yield nearly sixfold. Gram-negative bacteria predominated (70.8%), mainly Escherichia coli (37.5%), and Klebsiella pneumoniae (20.8%). ESBL production was universal, and 72.7% of Gram-negative isolates were carbapenem-resistant. Resistance genes included NDM (33.3%), VIM (8.3%), OXA-48 (4.2%), and mecA (12.5%). MDR pathogens caused 54.2% of infections. Appropriate empirical therapy was achieved in 62.5%. Intensive care unit (ICU) admission occurred in 29.1% of BSI cases. Overall mortality was 10.1%, with BSI-related mortality of 29.2%. Carbapenem-resistant infections significantly increased mortality (57.1% vs. 11.1%). Predictors of death included carbapenem resistance, ICU admission, and neutropenia >7 days. CONCLUSIONS: BSIs in neutropenic hematological patients are mostly caused by MDR Gram-negative organisms with high carbapenem resistance. RT-PCR substantially improves diagnostic sensitivity. Updated empirical therapy and stronger antimicrobial stewardship are urgently needed.
No takes yet. Share an insight, caveat, or question.
Najeeb et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: